GeneNews (TSE:GEN) Shares Down 7.7%

Share on StockTwits

GeneNews Ltd (TSE:GEN) shares dropped 7.7% during mid-day trading on Tuesday . The company traded as low as C$0.12 and last traded at C$0.12. Approximately 257,950 shares traded hands during trading, a decline of 83% from the average daily volume of 1,549,548 shares. The stock had previously closed at C$0.13.

The stock has a market cap of $21.45 million and a PE ratio of -1.62.

COPYRIGHT VIOLATION WARNING: “GeneNews (TSE:GEN) Shares Down 7.7%” was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4369863/genenews-tsegen-shares-down-7-7.html.

About GeneNews (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Further Reading: How can investors find ex-dividend dates?

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Business First Bancshares  Downgraded to “Sell” at Zacks Investment Research
Business First Bancshares Downgraded to “Sell” at Zacks Investment Research
Bloomin’ Brands  Upgraded to “Buy” by Zacks Investment Research
Bloomin’ Brands Upgraded to “Buy” by Zacks Investment Research
Brandywine Realty Trust  Stock Rating Upgraded by Zacks Investment Research
Brandywine Realty Trust Stock Rating Upgraded by Zacks Investment Research
Bain Capital Specialty Finance  Rating Lowered to Sell at Zacks Investment Research
Bain Capital Specialty Finance Rating Lowered to Sell at Zacks Investment Research
Brilliance China Automotive  Downgraded by Zacks Investment Research
Brilliance China Automotive Downgraded by Zacks Investment Research
SophiaTX Trading 1.8% Higher  This Week
SophiaTX Trading 1.8% Higher This Week


© 2006-2019 Ticker Report